SEI Investments’s Cardiff Oncology CRDF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$88.6K Buy
+54,685
New +$112K ﹤0.01% 3113
2020
Q4
Sell
-44,886
Closed -$637K 2467
2020
Q3
$637K Buy
+44,886
New +$296K ﹤0.01% 1802
2018
Q3
Hold
0
2645
2018
Q2
Hold
0
3637

Other funds holding CRDF

SEI Investments's CRDF Position: Q1 2026 in Review

SEI Investments opened a new position in Cardiff Oncology (CRDF) in Q1 2026: 54,685 shares worth $88.6K. The stake represents ﹤0.01% of the portfolio and ranks #3113 among its holdings. This is a return to the name: SEI Investments previously reported a position in CRDF as recently as Q3 2020.

SEI Investments first reported a position in CRDF in Q3 2020 and has held it in 2 quarters since. The position peaked at $637K in Q3 2020. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • SEI Investments held 54,685 shares of Cardiff Oncology worth $88.6K as of Q1 2026.
  • Cardiff Oncology was a new SEI Investments position in Q1 2026.
  • Cardiff Oncology made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #3113 holding.
  • SEI Investments first reported a position in Cardiff Oncology in Q3 2020 and has held it in 2 quarters since.
  • SEI Investments's Cardiff Oncology position peaked at $637K in Q3 2020.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.